Aprepitant Capsule
Product Images NDC 51407-702

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aprepitant (NDC 51407-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-701-05cb (Aprepitant 40mg mockup.jpg)

This is a description for Aprepitant Capsules, USP containing 40mg of aprepitant. The capsules are for adult use only, and the package is a bulk package not for dispensing and is not child-resistant. The product is manufactured by Pharmathen International S.A. and marketed by GSMS, Incorporated. The usual adult dosage information is available in the accompanying prescribing information. The capsules should be stored at 20 to 25°C with excursions permitted to 15° to 30°C. Barcode placement is indicated on the packaging.*

FDA Label Image

51407-702-06cb (Aprepitant 80mg mockup.jpg)

This text provides information about Aprepitant Capsules, USP containing 80 mg aprepitant, USP per capsule for adults and pediatric patients 12 years of age and older. It indicates that the product is not child-resistant and is meant for bulk packaging only. The manufacturer is Pharmathen International S.A. and it is marketed by GSMS, Incorporated. It mentions the usual dose instructions and storage conditions. The text also includes the manufacturer's address in Greece and the marketing company's address in the USA. The product is only for prescription (Rx only) and includes a barcode placement section.*

FDA Label Image

51407-703-06cb (Aprepitant 125mg mockup.jpg)

This text is a description of Aprepitant Capsules, USP in a dosage strength of 125mg. It is intended for use in adults and pediatric patients aged 12 years and older. The capsules are not child-resistant and come in a bulk package for distribution. The manufacturing details include the company Pharmathen International S.A in Greece and distribution by GSMS, Incorporated in the USA. Storage instructions recommend keeping the capsules at 20 to 25°C, with excursions permitted to 15° to 30°C. The usual dose and further prescribing information are provided separately.*

FDA Label Image

51407-704-03cb (Aprepitant 125g 80mg mockup.jpg)

This text provides information about Aprepitant Capsules, USP, in 80 mg and 125 mg strengths for adults and pediatric patients 12 years and older. It includes dosage instructions for a 3-day pack to be taken around chemotherapy treatment. The text also contains storage instructions, manufacturer details, and guidelines for taking the capsules.*

FDA Label Image

Structural Formula (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 01)

FDA Label Image

Figure 1 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 02)

This text provides results from two studies comparing the effectiveness of Aprepitant Regimen versus Standard Therapy. The data includes the number of participants in each group and outcome measures taken at various time points up to 120 hours. A log rank test was used to determine statistical significance, with a p-value less than 0.001 reported for both studies. Please note that the results are nominal and not adjusted for multiplicity.*

FDA Label Image

Figure 2 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 03)

This text appears to show data from two different studies evaluating the effectiveness of two different regimens (Aprepitant and Standard Therapy) in chemotherapy cycles. The number of participants in each group for both studies is provided, along with the results for each chemotherapy cycle. This data may be useful for comparing the effectiveness of Aprepitant and Standard Therapy in managing chemotherapy side effects.*

FDA Label Image

Figure 3 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 04)

FDA Label Image

Torrent Logo (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 05)

FDA Label Image

Logo (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.